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Gene products coded for by the D  and/or K  regions of the major histocompatibility 
complex  (MHC)'  must  play  a  determinant  part in  the  interaction  between  immune 
cytolytic T  lymphocytes (CTL) and their  virus-infected or hapten-modified syngeneic 
stimulating and targets cells, since a high level of specific cytolysis occurs only when both 
the CTL and the target cells possess shared H-2D and]or H-2K antigens (1-4).  The same 
phenomenon exists in the interaction between T-killer lymphocytes and syngeneic virus- 
induced tumor cells. This has been demonstrated both by immunization with oncogenic 
viruses (5-8) and by grafl~ of syngeneic virus producer lymphoma cells (9-11).  In murine 
sarcoma virus (MSV) tumors and in Friend virus (FLV) leukemias, such H-2 restrictions 
of CTL activity have been shown to occur during both primary in vivo response (5, 6, 9) 
and  secondary  in  vitro  CTL restimulation  (12). Some degree  of cytolysis exists  also 
against H-2 incompatible tumor cells induced by the same viruses especially when strong 
responses  are  elicited.  However quantitative  experiments,  with  different  effector to 
target cell ratios, demonstrate that such activity is 10-100 times weaker than that shown 
against H-2 compatible targets (12, 13). 
Though  the  exact  role  of H-2  directed  molecules  in  the  anti-MSV  and  anti-FLV 
reactions by syngeneic CTL is unknown, the hypothesis that the reactions are directed 
against altered self specificities as in other systems (1-4) appears more probable than the 
one requiring a double contact and sometimes designated as the intimacy theory (5, 9, 10, 
13). In most systems both Ho2D and H-2K have been implicated (1-4) but a predominant 
role of H-2K in vaccinia viral infection  (14) and of H-2D  in other systems (11, 15-19) 
including tumor antigens (11) has been noted. 
In the MSV tumor, we previously observed that one or the other regions of the 
MHC  was  involved  depending  on  the  H-2  haplotype  (13).  A  more  precise 
understanding  of the respective roles of H-2D, H-2K, and possibly other mole- 
cules  under  the  control  of the  MHC  is  necessary  to  determine  the  biological 
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significance  of the H-2  restriction phenomenon.  Moreover such studies  could 
help our understanding of the nature of the structural relationship between the 
cellular and viral products which together contribute to the altered self specific- 
ity. 
The results reported here,  obtained with mice of the H-2 ~ and H-2 d  haplo- 
types, demonstrate that the products of only one region of  the MHC are involved 
in the CTL/tumor target cells interaction. They are always directed by the D 
region with cells of the H-2 b haplotype, and by the K region end of  the MHC with 
cells of the H-2 d haplotype. 
Materials  and Methods 
Mice.  1-  to  2-mo-old  C57B1/6  (B6),  C57B1/10  (B10),  B10.WB  (WB),  B10.D2,  B10.A, 
B10.A(2R)(2R), B10.A(4R)(4R), B10.A(5R)(5R), HTI, HTG, BALB/c, BALB/B, C3H.OH, C3H.OL, 
A.TH, A.TL, A.TFR2, B10.T(6R)(6R), and B10.S(7R)(7R) were obtained from our own colonies. 
Viruses.  The MSV,  Moloney isolated,  was maintained by regular acellular transmission in 
newborn B6 or BALB/c. The NB tropic FLV was maintained in vivo in adult BALB/c or in vitro in 
the non-Fv-1 restricted 3T3-FL line which is derived from the National Institutes of Health Swiss 
mice (20). 
Target Cells.  These were transplanted ascitic viral lymphomas. In the H-2  b haplotype we used 
viral lymphomas of B6 mice:  MBL2  (Moloney),  RBL5  (Rauscher),  FBL3  (Friend),  and GiL  11 
(Graffi), or BALB/B mice: HFL/B (Friend) and A13 (Tennant). The nonviral EL4 tumor was used 
as a  negative control.  In the H-2  ~ haplotype all the viral lymphomas were of BALB/c origin: 
LSTRA  (Moloney),  BC1  (Tennant),  and T2  (Friend). The nonviral DBA/2 L1210 leukemia was 
used as control. MBL2, RBLS, and FBL3 were originally provided by Dr. R. Herberman (National 
Cancer Institute, Bethesda, Md.), HFL/B by Dr. F. Lilly (Albert Einstein College, Yeshiva Uni- 
versity, Bronx, N. Y.), A13, T2, and BC1 by Dr. B. Chesebro (National Institute of Allergy and 
Infectious Diseases, Rocky Mountain Laboratory, Hamilton, Mont.). 
Immune Lymphocytes.  Anti-MSV immune lymphocytes were taken from the spleens of mice 
inoculated intramuscularly (i.m.)  10-15 days previously with 0.2 ml of a  10  -~ dilution of MSV. 
Local tumours appeared 5-7 days after inoculation, reached their maximum at days 7-10,  and 
were completely rejected by day 15. Anti-FLV immune lymphocyte were obtained, only in the H-2 ~ 
haplotype, from the spleens of B6 mice inoculated 10-15 days before with 0.1 ml of a 10  -z dilution of 
FLV. 
The Chromium Release Test (CRT).  The CRT was performed as described previously (21) by 
using a  100:1 immune lymphocytes/target cell ratio and an incubation period of 6-16 h. The specific 
chromium release was measured in the presence of immune lymphocytes minus the chromium 
release in the presence of normal lymphocytes of the same line. Under our conditions a release of 
4% or more is clearly significant (21). In some of the experiments the results are expressed in terms 
of lytic units per 10  e effector cells. 1 lytic U was calculated according to Plata et al. (22) by using for 
comparison lymphoid/target cells ratios varying from 100/1 to 3/1 (see Table III). 
Concanavalin A  Restimulation of Immune Lymphocytes.  This technique is described in detail 
elsewhere:  2 2.5  x  107 splenic lymphocytes  from  MSV regressor mice were  cultured  in  25 cm  2 
culture  flasks by  using  15  ml  of RPMI  1640  medium  (Flobio,  France)  containing 5.10  -5  M  of 
2-mercaptoethanol  and  10%  of fetal  calf serum.  Normal  syngeneic lymphocyte  cultures  were 
run in parallel as a control. Concanavalin A (Con A) was added at a final concentration of 5 ~g/ml. 
After 7 days incubation the cells were harvested and tested in a  16-h CRT as described above. 
Immune Sera 
ANTI-H-2  b.  Different procedures of immunization were used.  (a) Antisera directed against the 
whole H-2  b were obtained from B10.D2 mice hyperimmunized against normal B10 lymphoid cells, 
or from BALB/c inoculated with normal BALB/B cells. In beth cases an in vivo absorption step was 
2 Reme, T., E. Gomard, and J. P. Levy. Specific activation ofanti-MSV T-killer lymphocytes by 
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used to obtain monospecific  anti-H-2D  b (adsorption into 5R) or anti-H-2K  b (absorption into 4R). (b) 
Antisera were also prepared so that they were directed only against H-2Db: (B10.RIII × B10.BR)FI 
anti-B10.A(4R), or against  H-2K  b products:  (B10.S(9R) ×  B10.H2~r)FI anti-B10.A(5R). (c)  In 
addition in some experiments we used antisera provided by Dr. F. Lilly (BALB/c × AKR)F~ anti- 
EL4 (anti-H-2b), (B10.A x HTI)FI anti-EL4 (anti-H-2D  b) and (B10.A × HTG)F~ anti-EL4 (anti-H- 
2Kb). 
ANTI-H-2  b.  Antisora  reacting with the whole H-2  d was obtained from B10 mice hyperimmu- 
nized with B10.D2 normal cells. Monospecific  antisora were obtained in the following two combi- 
nations: (B10.AKM × A.BY)F~ anti-B10.A (anti-H-2D  d) and (B10.A × A.BY)F~ anti-B10.D2 (anti- 
H-2Kd). 
A~rI-Ia.  Two anti-Ia sera were used: A.TH anti-A.TL (anti-Iak), and A.TL anti-A.TH  (anti- 
Ias). The anti-Ia  k reacts at least with Ia.3 and Ia.15 specificities of H-2  b lymphocytes and with Ia.15 
on H-2  b cells. The  anti-Ia  B  react with Ia.9 on H-2  b cells but does not react  with  any of the 
specificities identified on H-2  d lymphocytes. 
Blocking  by Anti-H-2  Sera.  Target cells incubated for 20 min at 4°C with 1/2 to 1/16 diluted 
anti-H-2 or anti-Ia immune  sera  were used  in the CRT, as described above, without  further 
washing. Controls were: (a) target cells incubated with nonimmune sora from the same mouse 
line.  (b) Target cells incubated  with the immune  serum  and  tested  in the CRT with normal 
(nonimmune) syngeneic lymphocytes. The fnal activity of the immune CTL was calculated by 
comparing  the  chromium  release  in  the  presence  of either  immune  lymphocytes or normal 
lymphocytes, the target cells being in both cases incubated with the immune serum. 
Results 
Cytolysis of  Lymphoma  Cells by In Vivo-Primed Anti-MSV  Spleen Cells from 
Different H-2 Recombinant Lines 
STUDY  IN  THE  H-2 ~ HAPLOTYPE.  Tumors  were  induced  in  different  inbred 
strains by i.m. inoculation with 1- to 2-mo-old mice with MSV. When the tumor 
size was maximal, at which point CTL activity is also expected to be maximal 
(21),  spleen  cells  were sampled  and tested  in the  CRT against different H-2 b 
lymphomas. The results were as follows: (a) effecter cells from B6 or B10 mice 
(H-2 b) were strongly cytolytic against all six FMRGi(+)1-1-2  b lymphomas tested 
(Table  I).  In other words  the  CTL  of B6  or  B10  mice  functioned with  equal 
efficiency regardless of whether the target lymphomas were from B6 or BALB/B 
origin, or induced by Rauscher, Friend, Graffi, Tennant, or Moloney viruses. (b) 
The same effector cells were not reactive against the nonviral EIA lymphomas 
(not shown).  (c) As previously reported (5,  13) BALB/c or B10.D2 effector cells 
were  unable  to  lyse  any  to  the  H-2 b  lymphoma  targets.  (d)  A  pattern  of 
reactivity similar to that found in B6 and B10 was also detected with effector 
cells from HTG, 2R, 4R, and WB mice (Table I). Mice of all of these strains share 
some part of the D  end of the MHC with the H-2 ~ lymphomas. This common part 
is limited to the D  region in 2R and WB.  The same situation also exists with 
HTG, which in addition differs from the B6 and BALB/B targets by numerous 
non-H-2 antigens. It has been found previously however that the non-H-2 genes 
do not play a role in the CTL/target cells interactions (5, 13). It must therefore be 
concluded that an identity limited to the D b region is sufficient for a  strong CTL 
activity against H-2 b viral  lymphomas.  (e)  Anti-MSV-CTL from 5R and  HTI 
were unable to kill any 1-1-2  b targets, or were marginally efficient. This suggests 
that H-2K  b or other molecules coded by the K  region are not involved in the anti- 
MSV CTL activity. This probably holds also for Ia antigens since the K, I, and S 
regions  are  identical  in  HTI effectors and in targets  of BALB/B or B6 origin 
differences being restricted to the D  region. b
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One can  conclude  therefore  that  an  identity  of  the  CTL and  the  targets  limited 
to  the  D region  is  both  necessary and  sufficient  to  allow lytic  interactions.  In  all 
these  experiments  the  complete  and  specific  abrogation  of  the  spleen  cell  activity 
by anti-Thy 1.2 serum and complement was verified  showing that the effector 
cells  are T cells  (results  not shown). This is  in  agreement with previous  results 
obtained  in  the MSV system (23,  24).  The  presence  of  both  normal H-2K  b  and  H- 
2D  b  antigens on the six  FMRGi  (+) lymphomas employed was shown by their 
sensitivity  to lysis  by allogeneic  anti-H-2K  b  CTL or anti-H-2D  b  CTL. 
STUDY IN THE d HAPLOTYPE.  The same type of experiments were done by 
using three FMRGi  (+) H-2  d lymphomas (Table  II).  These showed that (a) 
BALB/B (I-I-2  b) CTL which  were  very  efficient  against  H-2  ~  targets  (Table  I  and 
reference  13) are inactive  against  1-1-2  ~ cells.  Identical  results  were found with 
B6 and B10-CTL (results  not shown). (b)  BALB/c and B10.D2 (H-2  d) anti-MSV 
spleen cells  are strongly  lytic  for all three 1-1-2  d lymphomas, without killing 
the nonviral H-2  d L1210 leukemia cells  (not  shown). (c) Among the 1-1-2 re- 
combinant strains,  C3H.OL, C3H.OH, and HTG  produce anti-MSV-CTL with 
a pattern  of  reactivity  identical  to  that  of  B10.D2 or  BALB/c. All  of  these  strains 
share in  common the  K  and  I regions  of  the MHC, differences  with the targets 
being restricted  to the D  or  D+S  regions.  (d) On the contrary A.TH, A.TL, 
A.TFR2, HTI, 5R, 6R, and  7R  which  share at  least  theD  d  region  in  common with 
BALB/c, but are different  at the  K  end of  the MHC, do not produce anti-MSV 
effector  cells  capable  of  lysing  the  BALB/c target  cells.  On a  few  occasions,  A.TL 
anti-MSV spleen cells  were found with a low degree of  activity  for  the LSTRA 
(I-I-2 d) targets, as already reported (13). This apparent discrepancy was observed 
more frequently and with a higher level of lysis with B10.A anti-MSV effector 
lymphocytes.  However these  exceptional  reactions  could not be abolished by 
anti-Thy  1.2 treatment  of the effector cells their pattern of specificity differed 
from the  usual  anti-MSV,  or  anti-FLV-CTL  pattern.  The  B10.A  spleen  cells 
from anti-MSV immune animals were found to lyse t-I-2 d targets in about 25% of 
the experiments, but in these same experiments they showed a similar degree of 
activity for nonviral lymphomas, and also for viral but 1-1-2 incompatible tumors 
such as MBL2 (H-2b). We therefore conclude that these reactions were directed 
against antigens other than those responsible for syngeneic anti-MSV reactions, 
and that such cytolysis being mediated by non-T cells, they are therefore not 
relevant to the response studied here. 
On the whole it appears that T-cell-mediated cytolysis of H-2  d targets by anti- 
MSV spleen cells require that the effector cells possess the K  end of the MHC 
identical to that of the target cells. It cannot be determined from these experi- 
ments if it is the K d or the I d regions or both which are concerned. It can however 
be concluded that the D region is not involved. The presence of normal nonmodi- 
fled H-2D  d and H-2K  d antigens at the cell surface was verified by the demonstra- 
tion that all three of the H-2 d viral lymphomas used in these experiments are 
killed by allogeneic anti-H-2D d or anti-H-2K  d CTL (Table II). 
Cytolysis of H-2 b and H-2 d Viral Lymphomas  by In Vitro Restimulated Anti- 
MSV  Spleen  Cells.  According  to  the  altered  self hypothesis  the  preceding 
results would indicate that the anti-MSV CTL recognizes antigens associating a 
viral  product  and  the  H-2D b or the  H-2K  d molecules  on  the  lymphoma  cell 914  EXCLUSIVE  INVOLVEMENT  OF  H-2D ~  OR  H-2K ~  PRODUCTS 
TABLE II 
Cytolysis of H-2  d Lymphoma Cells by Anti-MSV CTL  * from Different Lines 
Effector cells  Percent chromium release from target ceils* 
Immune spleen cells  H-2 haplotype  H-2  region  common  to  LSTRA  BC1  T2 
donors  K  I  S D  effector  and  target  (BALB/c)  (BALB/c)  (BALB/c) 
A B  C  cells 
BALB/c anti-MSV  d  d  d  d  d  d 
BALB/B anti-MSV  b  b  b  b  b  b 
B10.D2 anti-MSV  d  d  d  d  d  d 
C3H.OH anti-MSV  ~"~d  d  k 
C3H.OL anti-MSV  dd~d~d  k  k 
HTG anti-MSV  d 
HTI anti-MSV  b  b  b  b  b 
B10.A(5R)  anti-MSV  b  b  b  d 
B10.A anti-MSV  k  k  k  d 
A.TL anti-MSV  s  k  k  k 
A.THanti-MSV  s  s  s  s  si 
B10.S(7R) anti-MSV  s  s  s  s  s 
B10.HTT anti-MSV  s  s  s  k  k 
B10.T(6R) anti-MSV  q  q  q  q  q 
ATFR/2 anti-MSV  f  f  f  f  s 
B10.A(2R) anti-MSV  k  k  k~-~  b 
B10 anti-B10.A(5R)§  b  b  b  b  b  b 
C3H anti-C3H.OL  k  k  k  k  k  k 
all H-2  60  41  39 
none  3  0  0 
all H-2  37  29  27 
K to S  43  31  31 
K to I-C  27  30  27 
K to S  36  30  24 
D  3  0  0 
I-C toD  0  0  0 
I-Cto D  8  4  7 
D  4  0  0 
D  0  0  3 
D  0  -  - 
D  0  -  - 
D  0  0  0 
D  0  4  4 
I-Cto S  4  3  4 
none  27  20  18 
none  20  22  16 
* Effector to target cell ratio:  100/1,  18 h incubation. 
* See footnote~ Table I. 
§ B10 were immunized by i.p. inoculation  of 5.107 B10.A(SR) normal spleen cells 6 days before to produce anti-H-2D d CTL. 
surface.  Thus  these  new  antigens  can  tentatively  be  called  H-2D b/MuLv and 
H-2K d/MuLv (H-2D b and  H-2K d altered  by  murine  leukemia  viruses).  On  the 
other hand no reaction was detected against the hypothetic H-2K b/M~Lv and H- 
2D  d/MuLv. Because the activity of in vitro-primed CTL is relatively weak such a 
discrepancy might be purely quantitative.  To confirm the absence of reactivity 
of H-2K b and H-2D d we restimulated in vitro the anti-MSV spleen cells obtained 
from those strains which were non responders when tested in vivo. To avoid the 
induction of an anti-H-2D b or anti-H-2K d reactions,  restimulations  of in vivo- 
primed spleen cells were done by culturing these cells for 7 days in the presence 
of Con  A.  As  previously  reported  for  other  systems  (25-27)  and  repeatedly 
demonstrated  for  the  anti-MSV  response, ~ such  a  procedure  yields  specific 
reactivation  of the  immune  CTL  indistinguishable  from  that  expected  of a 
secondary response. 
As  shown  in  Table  III,  activated  B6  anti-MSV-CTL  obtained  in  this  way 
specifically killed FMRGi (+) H-2  b targets.  They remained ineffective however 
for FMRGi  (-) H-2 b lymphoma cells and for FMRGi  (+)  H-2  d targets  (results 
not shown). Similar results were obtained with 4R effector cells, whereas 5R and 
HTI remained ineffective regardless of the tumor tested. The absence of reactiv- 
ity of HTI and 5R cells is specially significant since under the same conditions of 
restimulation the B6 and 4R activity was greatly increased.  One can conclude 
that even highly stimulated spleen cells from HTI and 5R immunized with MSV 
do not react with the postulated H-2K bIMuLV specificity. Similar conclusions can 
be derived from the experiments performed on the H-2 d haplotype. The spleen 
cells of BALB/c and C3H.OH which were cytolytic for H-2 d targets aider in vivo GOMARD,  DUPREZ,  REME,  COLOMBANI,  AND  LEVY  915 
TABLE  Ill 
Cytotoxic  Activity of Immune Spleen Cells after Con A In Vitro Restimulation* 
14-2 region  Percent specific chromium release of tar- 
Immune spleen  Days in  Target  common to  get§  LU/IO~ 
ceils  vitro  cells  CTL and tar- 
get cells  100:111  30:1  10:1  3:1  1:1 
C57BL/6 anti-MSV  0t  MBL2  all H-2  30  18  8  6  2  0.3 
0  LSTRA  none  3  6  0  0  0  0 
7  MBL2  all H-2  73  67  60  40  -  18.5 
7  LSTRA  none  28  18  7  0  -  0.2 
B10.A(4R) anti-MSV  0  MBL2  I-B to D  43  24  12  4  0  0.7 
0  LSTRA  none  0  0  0  0  0  0 
6  MBL2  I-B to D  64  53  38  19  2  4..~1 
6  LSTRA  none  0  0  (~  0  0  0 
9  MBL2  I-B to D  83  77  49  17  9  8.7 
9  LSTRA  none  0  0  0  0  0  0 
B10.A anti-MSV  0  MBL2  K to I-B  5  0  0  0  0  0 
0  LSTRA  none  0  0  0  0  0  0 
7  MBL2  K to I-B  0  0  0  0  0  0 
7  LSTRA  none  0  0  0  0  0  0 
9  MBL2  K to I-B  0  0  0  0  0  0 
9  LSTRA  none  0  0  0  0  0  0 
HTI anti-MSV  0  MBL2  K to S  2  0  0  0  0  0 
0  LSTRA  none  0  0  0  0  0  0 
7  MBL2  K to S  0  0  0  0  0  0 
7  LSTRA  none  0  0  0  0  0  0 
A.TH anti-MSV  0  MBL2  none  0  0  0  0  -  0 
0  LSTRA  D  0  0  0  0  -  0 
7  MBL2  none  0  0  0  0  -  0 
7  LSTRA  D  0  0  0  0  0 
C3H.OH  anti-MSV  0  MBL2  none  0  0  0  0  -  0 
0  LSTRA  K to S  18  14  9  0  -  0.1 
7  MBL2  none  7  5  0  0  -  0 
7  LSTRA  K to S  80  72  52  10  1...~1 
BABL/c anti-MSV  0  MBL2  none  5  0  0  0  0 
0  LSTRA  all H-2  25  12  7  0  -  0.2 
7  MBL2  none  11  5  0  0  -  0 
7  LSTRA  all H-2  51  39  10  0  1 
* Spleen cells were sampled 17 days after MSV inoculation at a time when the tumors were completely rejected, about 7 days alter 
the maximum of the primary CTL response. 
Day 0; activity of in vivo-primed nonrestimulated spleen cells. Day 6-9: activity of samples CTL in vitro eeeultivated during 6-9 
days with Con A. 
g Mean standard errors were always between 0.3 and 2.2%. 
[I CTL to target cells ratios. 
The lymphoid to targets ratio giving at 16 h  50~ specific chromium release (as compared to the maximum chromium release 
obtained by HCI minus the chromium release in controls) was calculated from curves plotting percent chromium release versus 
L/T ratios (log).  It allowed us to calculate the number of cells necessary for one lyric unit and therefore the number of lytic units 
per million effector cells. 
priming, displayed greatly increased activities after in vitro restimulation,  and 
these activities remain virus specific, since nonviral L1210 cells are not lysed, 
and H-2 restricted, since the restimulated cells were unable to kill 1t-2  b targets. 
On the contrary the spleen  cells  of A.TH,  HTI,  and  B10.A  (5R) which were, 
ineffective in vivo, remained so after in vitro culture with Con A. 
Blocking  of  the  Anti-MSV-CTL  Activity  by  Monospecific  Anti-H-2  Se- 
rums.  It has been shown previously that incubation of tumor cells with related 
anti-H-2  antibodies  completely  and  specifically  abolishes  their  sensitivity  to 
cytolysis  by  syngeneic  anti-MSV-CTL  (5).  This  observation  suggests  a  close 916  EXCLUSIVE  INVOLVEMENT  OF  H-2D b  OR  H-2K ~  PRODUCTS 
topographical relationship between H-2 molecules and viral antigens, support- 
ing the altered self  hypothesis. In the present experiments advantage was taken 
of  this phenomenon to study the nature of  the altered H-2 antigens of oncornavi- 
ruses  induced lymphoma cells.  After  incubation with  monospecific anti-H-2 
antibodies of different origins,  the  lymphoma cells  were tested  in the  CRT. 
Relatively weak activities were frequent in the positive controls of  these experi- 
ments and are due to the short incubation periods used in the CRT tests (6 h). 
STUDY IN THE  H-2b HAPLOTYPE.  Lymphoma cells of B6  or  BALB/B  (H-2 b) 
were incubated with antisera reacting against the whole haplotype of the H-2 
haplotype, or only against the products of  the D or K regions and then exposed to 
syngeneic anti-MSV or anti-FLV-CTL. The results (Table IV)  can be summa- 
rized as follows: (a) anti-H-2  b and anti-H-2D  b typing sera inhibit the activity of 
H-2 b anti-MSV  or anti-FLV-CTL.  (b)  Anti-H-2K  b sera  are  completely ineffi- 
cient. (c) Samples of  the same anti-H-2K  b are however able to block the activity 
of allogeneic anti-H-2K  b CTL  toward the  same target cells.  (d)  Anti-Ia  are 
ineffective as blocking sera.  Similar results were obtained with all six 1-1-1b 
FMRGi (+)  lymphomas tested  (Table V).  On the whole the results from the 
above experiments (Table IV) suggest that normal H-2K  b antigens are present 
on the surface of the FMRGi (+) H-2  b lymphomas and are able to react with the 
anti-H-2K  b allogeneic CTL. These antigens are accessible to anti-H-2K  b anti- 
bodies, since the latter can inhibit the cytolysis by allogeneic anti-H-2K  b CTL. 
However the H-2K  b molecules, unlike the H-2D  b, do not seem to be altered by 
the  product  of type  C  virus  genome present  at the  lymphoma cell  surface. 
Equally Ia specificities are apparently not concerned. 
STUDY IN  THE  H-2  d HAPLOTYPE.  Blocking experiments were performed with 
the three available lymphomas of the H-2 d haplotype (Table VI and VII).  In 
agreement with the results reported above in this haplotype the results were the 
following: (a) anti-H-2  d and anti-H-2K  d sera block the cytolysis of H-2  d targets 
by  H-2 d anti-MSV-CTL.  (b)  Anti-H-2D  ~ do not block  the  same  reaction.  (c) 
Samples of  the anti-D  d sera inhibit the cytolysis  of H-2  d tumor cells by allogeneic 
anti-H-2D  ~ targets. (d) Anti-Ia are ineffective as blocking sera. Identical results 
were obtained with all three FMRGi (+) H-2 d lymphomas (Table VII). It can be 
concluded that in the H-2 d, as in the H-2 b haplotype, only one end of the MHC 
undergoes interaction with viral antigen, significant for cell-mediated lysis of 
oncornaviruses induced lymphoma cells. The involved region is different in the 
two H-2 haplotypes tested. 
Discussion 
These  results  obtained  from the  study of nine  tumors  show  that:  (a)  an 
identity of the D  region of the H-2 complex is necessary and sufficient to allow 
the  cytolysis of H-2 b  oncornaviruses  induced  lymphoma cells  by  syngeneic 
immune CTL. (b) An identity of the K end is necessary and sufficient when the 
tumor cells bear the H-2 d  specificity. Blocking experiments with tumor cells 
preincubated with monospecific anti-H-2 sera are clearly consistent with the 
notion that the interaction between syngeneic effector and target cells involves 
exclusively the products of  one region of  the MHC: D  b or K ~. The H-2D  d or H-2K  b 
antigens however, normally represented on the H-2 d or H-2 b tumor cells are GOMARD,  DUPREZ,  REME,  COLOMBANI,  AND  LEVY  917 
TABLE IV 
Cytolysis of MBL 2(H-2 b) by Anti-MSV, Anti-FL  V, and Allogeneic Anti-H-2 b CTL: 
Selective Effect of Specifically Directed Anti-H-2 Sera 
MBL2 targets preincubated  with: 
Percent  specific chromium release*  of the target cells in the 
presence of: 
B10.D2 anti- 
BALB/c anti° 
B6 anti-MSV  B6 anti-FLV  B10.A(5R)§ 
Serums  Specificity  CTL  CTL  B6 (anti-H-2 b)  (anti-H-2KG) 
CTL 
CTL 
No  / 
Normal mouse serum  / 
AKR anti-C3H thymocytes  anti-Thy  1.2 
BI0.D2 anti-B6  anti-H-2  b 
(BALB/c × AKR)F~ anti-EL4  " 
B10.D2  anti-B6  in  vivo  ab- 
sorbed in 4R 
(B10.A  x  HTG)F1 anti-EL4 
(B10.S(gR)  ×  B10.HTT)Fz 
anti-SR 
anti-H-2K b 
28  27  31  17 
26  31  30  16 
27  28  -  - 
0  4  2  0 
2  3  -  - 
27  -  12  0 
26  28  -  - 
25  29  18  5 
B10.D2  anti-B6  in  vivo  ab-  anti-H-2D b  2  -  17  15 
sorbed  in 5R 
(B10.A  ×  HTI)F2 anti-EL4  0  0  -  - 
(B10.RIII  x  B10.BR)F~  anti-  3  3  -  - 
4R 
A.TL anti-A.TH  anti-Ia~[  29  29 
A.TH anti-A.TL  anti-Iak¶  30  29 
* Effector  to targets ratio  100/1, 6 h  incubation,  mean standard  errors between  0.5 and 2%. 
The antisora bad approximately  equivalent  titers:  1/1,000-1/2,000  in complement-dependent  cytotoxicity. 
§ Anti-H-2 ~ and anti.H-2K b immunizations  were obtained by one i.p.  inoculation  of 5.10  v normal spleen cells 6 days before. 
[[ Reacting at least with Ia.9 on MBL2 cells. 
¶  Reacting at least with Ia3 and Ia15 on MBL2 cells. 
TABLE V 
Selective Effects of Specifically Directed Anti-H-2 Sera on the Lysis of Six Different H-2 ~ 
Lymphomas by B6 Anti-MSV CTL 
Target cells  preincubated with:  Percent  specific chromium release of the target cells* 
MBL2  GiL 11  RBL5  FBL3  HFL/B  A13 
Sera  Specificity  (B6)  (B6)  (B6)  (B6)  (BALE/B)  (BALB/B) 
Normal  mouse sera  16  10  15  16  18  13 
B10.D2 anti-B6  anti-H-2 b  0  0  0  0  2  3 
B10.D2  anti-B6  in vive  anti-H-2K b  17  13  15  13  17  21 
absorbed  in 4R 
B10.D2  anti-B6  in vivo  anti-H-2D b  2  0  2  3  2  0 
absorbed  in 5R 
* Effector  to target cells ratio 10011, 6 h  incubation. 
perfectly able to function as target for allogeneic anti-H-2 CTL. These results 
suggest the existence of a specific interaction between a viral product and some 
molecule coded for by the MHC, these molecules differing with the H-2  haplo- 
type. 
The exclusive involvement of only one product of the MHC in the interaction 
between T-killer cells and syngeneic viral lymphomas is not the property of a 
given  type C  virus,  since the  nine  tumors  tested in  these experiments  were 
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TABLE  VI 
Cytolysis of LSTRA  (H-2  d) by Anti-MSV and Anti-H-2 d CTL Selective Effect of 
Specifically Directed Anti-H-2 Sera 
LSTRA preincubation with: 
Serums  Specificity 
Percent specific chromium release* of 
the target cells in the presence of: 
C3H anti-  B10 anti- 
C  anti-  C3H.OL§  B10.A(5R)§ 
MSV  (anti-H-  (anti-H- 
2K  d)  2D  d) 
No  / 
Normal mouse serum  / 
AKR anti-C3H thymocytes  anti-Thy 1.2 
B10 anti-B10.D2  anti-H-2  d 
(B10.AKM ×  ABY) anti-B10.A  anti-H-2D  d 
B10  anti-B10.D2  in  vivo  ab-  anti-H-2D  d 
sorbed in B10.A(5R) 
(B10.A  x  ABY)anti-B10.D2  anti-H-2K  d 
B10  anti-B10.D2  in  vivo  ab-  anti-H-2K  d 
serbed in C3H.OL 
A.TL anti-A.THII  anti-Ia  s 
A.TH anti-A.TL¶  anti-Ia  k 
13  20  17 
15  25  20 
15  -  - 
0  0  2 
16  27  0 
12  22  - 
0  0  21 
0  0  - 
14  -  - 
16  -  - 
*, $, §, see footnotes *, $, § Table IV. 
H  No identified specificity reacting in this system. 
¶ Reacting at least with Ial5 or LSTRA cells. 
TABLE  VII 
Selective Effects of Specifically Directed Anti-H-2 Sera on the Lysis of Three Different 
H-2 d Lymphomas by C Anti-MSV CTL 
Target cells preincubated with: 
Percent specific chromium release of 
the target cells* 
Sera  Specificity  LSTRA  BC1  T2 
Normal mouse sera 
B10 anti-B10.D2 
(B10.AKM  x  ABY)anti-B10.A 
(B10.A  ×  ABY) anti-B10.D2 
-  15  17  14 
anti-H-2  d  0  0  0 
anti-H-2D  d  16  15  16 
anti-H-2K  d  0  2  0 
* Effector to target cells ratio:  100/1, 6 h  incubation. 
nant leukemia-viruses. Moreover it was observed for both anti-MSV and anti- 
FLV attacker cells. It must however be noted that the five agents share several 
biological or pathological properties,  and that the tumor cells tested have in 
common the FMRGi (+) serological specificity. One could suppose therefore that 
the same, or a  closely related, viral protein is involved in all five cases in the 
interaction with the H-2 molecules. In other systems involving T-killer cells, it 
seems that normally both H-2D and H-2K specificity can function (1-4). In the H- 
2 b haplotype reactions involving the K b antigens have been reported in response 
to nononcogenic viruses infections (15) or during immunization against hapten- 
modified syngeneic cells  (16).  In  both  cases,  5R  effector cells  were  efficient 
against H-2  b targets, unlike the results described above in the MSV system. A 
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interaction  between  H-2  b targets  and  allogeneic  (but  H-2  compatible)  CTL 
reacting with minor histocompatibility antigens (17), including the H-Y specific- 
ity  (18).  In  the  1-1-2  d  and  I-1-2  k  haplotypes  both  K  and  D  region-directed 
molecules  seem  to  be  involved  in  viral  (19)  and  haptenic  (16)  systems.  An 
exclusive  involvement  of a  D  region  product  was  described  in  an  antitumor 
response (11) whereas we have found an exclusive involvement of the K  end of 
the t-I-2 d  haplotype in oncornaviruses  systems. We know,  in addition,  that  a 
product of the K  region is also strongly antigenic in the MSV system when H-2  k 
mice are tested (13).  A similar exclusive involvement of the K k specificity was 
reported in an anti-vaccinia viral immunization (14). One can conclude therefore 
that the product of the MHC involved in the self alteration may depend on the 
nature  of the  CTL-triggering  factor.  In  some cases only one product  may be 
concerned  and  this  may be especially true  for  antitumor  responses  (11,  and 
present results)  making these systems particularly  useful for the study of the 
biological significance of the H-2 restriction phenomenon. 
The  exclusive  involvement  of only one  H-2 directed  molecule in  the  CTL/ 
target cell interaction can be explained by at least three different hypotheses: (a) 
several H-2 antigens are modified by the viral infection and/or transformation, 
but only one of them is antigenic for syngeneic T-killer cells precursors. (b) Only 
one H-2 product is involved because the viral proteins, or glycoproteins, have a 
specific relationship with this H-2 molecule.  (c) The molecules involved in the 
interaction  are not H-2 antigens but other cell surface component coded for by 
closely linked genes. 
The  first  hypothesis  is  supported  by previous observations  in  the  trinitro- 
phenyl-modified cell system  (16).  It implicates  that Ir  genes control the  CTL 
generation  in response to MSV or FLV infection,  and that all the mice so far 
tested bear  a  nonresponder  allele  at  the Ir  gene  locus  directing  the  anti-H- 
2K  b/MuLv or the anti-H-2D  ~MuLv responses.  Systematic experiments with differ- 
ent F1 hybrids between the nonresponder strains, for example 5R and HIT in the 
/-/-2 b experiment,  and other non-H-2 inbred strains  of mice might resolve this 
problem if one of the hybrid was able to react with the 1-1-2 ~ lymphomas.  Such 
experiments have been successful in the TNP system (16) and have allowed for 
the description of CTL-controlling Ir genes in the I  region of the MHC. Similar 
experiments are now in progress in the MSV system to test further this hypothe- 
sis which cannot be definitively excluded. 
The  second  hypothesis  suggests  that H-2D  b/MuLv and  H-2K  d/MuLv do exist 
whereas H-2K  bIMuLv  and H-2D  djMuLv  do not.  This implies that viral  products and H- 
2K  d  or H-2D  d  cannot interact  to produce an altered self  structure. The exclusive 
affinity  of  viral  proteins for H-2D  b can be supported by the recent observations 
that H-2D  b antigen,  to the exclusion  of any other H-2 specificities,  can be 
detected  inside FLV  virions produced  in H-2b/H-2  d heterozygotes  (28). This 
observation demonstrates, that the inclusion of  H-2 molecules into  type C virus 
particles is selective  rather than random. It is interesting to observe that the 
same association between H-2D  b  and viral  structures already exists  at the host 
cell  surface in H-2  b  producer cells,  suggesting that H-2D  b  antigens may possibly 
play a specific  role  in viral assembly. According to this assumption one expects 
that H-2K  d  but not H-2D  d  antigens should be present inside  the virions  produced 
in H-2  d  cells.  Good evidences for  the physical association between FLV antigens 920  EXCLUSIVE  INVOLVEMENT  OF  H-2D b  OR  H-2K d  PRODUCTS 
and H-2D  b molecules have been also obtained by capping of  the viral antigens on 
H-2 b tumor cells, since a partial cocapping of H-2D  b but not H-2K  b was observed 
(29). The latter experiment, however, does not demonstrate that the capping 
antigen is the same as the antigens reacting with the CTL. 
The third hypothesis is that H-2 directed molecules distinct from H-2D and H- 
2K antigens are involved in the CTL/target cell interactions. At least two cell 
surface components should be discussed: Hh antigens (30) and the hypothetical 
product of the RFV/1 gene (31). The involvement of Hh rather than H-2 mole- 
cules cannot be ruled out since the Hh. 1 specificity is coded for in the D  region 
and the Hh.3 in the K region of  the MHC. An apparent exclusive involvement of 
the D  b and K d regions would be predicted in the combinations we have studied if 
Hh molecules were concerned since anti-Hh. 1 reactions are strong against H-2  b 
targets  and anti-Hh.3 against H-2  d and H-2  K  targets,  (G. Cudkowicz, personal 
communication).  The hypothetical product of the RFV/1 gene must be also 
considered  since  this  gene  which maps to  the  D region  (31)  controls  resistance  to 
the FLV induced disease.  Moreover it  has been suggested that  the RFV/I gene 
acts  by directing  the persistance  or elimination  of  viral  antigens from the host 
cell  surface (32),  which might be achieved by the specific  association  of  viral 
proteins  and a normal cell  surface  structure.  However the observation  that a  K 
end  product is  involved  in  the  CTL/target  cells  interaction  in  the  H-2  d  haplotype 
does  not  support  the  idea  that  an  RFV/1 gene  product  would  be  concerned in  this 
case. 
Summary 
It was demonstrated previously that the cytolysis of murine viral lymphoma 
cells by anti-murine sarcoma virus (MSV)  syngeneic T-killer lymphocytes was 
restricted  by  some  products  of the  H-2  complex.  The  respective  role  of the 
products of different regions of the H-2 complex were studied with six H-2 b and 
three H-2 d  lymphomas induced by five different type C  viruses.  They were 
tested  in  a  classical  chromium release  test  against  anti-MSV  T-killer  cells 
obtained from different inbred strains of mice, including several H-2 recombi- 
nants. Tumors o£ the H-2 b haplotype were lysed only when effectors and target 
cells have in common theD b region. On the contrary an identity limited to theK 
end of the H-2 complex is necessary and sufficient in the H-2 d haplotype. An in 
vitro restimulation of the spleen cells with concanavalin A strongly increased 
the activity of in vivo-primed T lymphocytes  but did not provide any response for 
in vivo-primed but nonresponder cells.  Preincubation of the tumor cells with 
anti-H-2 sera abolished the lysis by syngeneic anti-MSV effector lymphocytes. 
The same results were obtained by preincubating the H-2  b targets with anti-H- 
2D  b, or the H-2 d target with anti-H-2K  d. Preincubation with anti-H-2K  b or anti- 
H-2D  d were ineffective. These results show that the T-killer/target cells interac- 
tion in the MSV system involved some products of  the H-2 complex which might 
be different with the various H-2 haplotypes and could possibly vary according 
to  the  antigenic specificity. A  specific  association of a  viral  product  with  a 
normal cellular structure, directed by the H-2 region during the viral budding 
could explain the observed results. 
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